Raja (Eladnani) Prince/LinkedIn
Dec 4, 2025, 02:34
Raja Prince and Team: Protein S as a Therapeutic Target
Raja Prince, Founder and BOD of BLEEDnFIRE Therapeutics, posted on LinkedIn:
”I’m delighted to share our newly published review in Journal of Thrombosis and Haemostasis (JTH).
In this article, our team provides an updated and comprehensive overview of protein S as a therapeutic target, summarizing current knowledge, emerging therapeutic strategies, and key challenges in the field of hemostasis.
A big thank you to my two coauthors, Rim Diab and Anne Angelillo-Scherrer.”
Read the full article here.
Title: Protein S as a therapeutic target
Authors: Raja Prince Eladnani, Rim Diab, Anne Angelillo-Scherrer
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 10:33Johanna Rodríguez: The Structural Challenge of Next-Gen Anticoagulants
-
Jul 23, 2026, 10:27Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
-
Jul 23, 2026, 09:05Fonkou Steve: What If We’ve Been Asking the Wrong Question About Plasma Too?
-
Jul 23, 2026, 08:27Registration Is Now Open for ASH 2026
-
Jul 23, 2026, 08:19Sheeza Nawaz: Why Do Patients With Aortic Stenosis Bleed?
-
Jul 23, 2026, 07:59Paschalis Karakasis: Can Left Atrial Appendage Closure Truly Replace Oral Anticoagulation?
-
Jul 23, 2026, 06:53Lakmali Silva: What Makes ISTH More Than a Scientific Meeting?
-
Jul 23, 2026, 05:48Paschalis Evangelidis: Rethinking Pulmonary Embolism Through the Lens of Thromboinflammation
-
Jul 23, 2026, 05:35Neil Morgan: Honoured to Lead the Platelet and Megakaryocyte Theme at ISTH 2026